CVS Caremark gets 2Q profit lift from new generics
Introductions of new generic drugs helped boost profits at CVS Caremark Corp. for the second quarter as the company exceeded Wall Street’s earnings forecast by a penny. CVS said Tuesday that for the second quarter ended June 30, income from continuing operations attributable to CVS Caremark rose 15.